Delivery Order SPE2DE24D0013-SPE2D625F5V7X
- Not listed
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,096.80 firm fixed-price delivery order by the Medical Supply Chain (Defense) on June 30, 2025, with an ultimate completion date of July 15, 2025. The contract, designated as XPCOV2/FLU/RSV-10, carries no set-aside designation and specifies performance in Sunnyvale, California. This delivery order pertains to molecular diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $6,631.72 firm fixed-price delivery order by the Defense Department's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPCOV2/FLU/RSV-10, calls for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic products and services, with performance occurring at Cepheid's Sunnyvale facility. This award carries...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a $4,198.65 firm fixed-price delivery order from the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for the delivery of diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with an ultimate completion date of September 19, 2025. This contract award carries no set-aside...
- Cepheid, a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $13,096.80 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and is scheduled for completion by October 2, 2025. Based on the contract designation and Cepheid's core product offerings, this delivery order appears to procure...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F5V7XDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale, California, leveraging Cepheid's established expertise in molecular diagnostic technologies for infectious disease detection. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs, which has previously engaged the company for PCR testing and molecular diagnostic reagents and assays. Cepheid's federal contract portfolio demonstrates consistent provision of diagnostic equipment and testing services across multiple VA Veterans Integrated Service Networks and the Defense Health Agency, positioning the company as a key supplier of point-of-care molecular diagnostics for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 5/2/25 |